Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DURATION UTI trial of antibiotic treatment duration in adult women with urinary tract infection
ISRCTN18390724Phase 4Completed
- Sponsor
- University of Oxford
- Start
- Jul 2023
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of nitrofurantoin and pivmecillinam in urinary tract infection (UTI), cystitis and pyelonephritis (16 arms), sponsored by University of Oxford. Primary endpoint: Sustained clinical cure without medically attended symptomatic recurrence through day 42. Started Jul 2023; status: completed.
02
Drugs
nitrofurantoinpivmecillinam
03
Conditions
urinary tract infection (UTI)cystitispyelonephritis
Beyond the preview
Go deeper on ISRCTN18390724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN18390724.